Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Rituximab (R)-CHOP Therapy Has Progressed Arteriosclerosis with an Elevation of Von Willebrand Factor (vWF) in Patients with Malignant Lymphoma

Naomi Shimizu, MD, Shouko Nakamura, MD, Naoyuki Kawagoe, MD PhD, Rena Oka, MD PhD, Yasuhiro Watanabe, MD PhD, Sho Tanaka, MD, Yuta Sato, MD PhD, Takashi Yamaguchi, MD PhD, Masahiro Ohira, MD PhD, Atsuhito Saiki, MD PhD, Chiaki Nakaseko, MD PhD, Emiko Sakaida, MD PhD, Hideaki Bujo, MD PhD, Kohji Shirai, MD PhD, Ichiro Tatsuno, MD PhD

Blood (2018) 132 (Supplement 1): 5380.

https://doi.org/10.1182/blood-2018-99-112326

Published: 2018

Journal Articles

Arterial Function Deterioration Is Accelerated in Patients with Essential Thrombocythemia

Ajda Anzic Drofenik, MD, Matjaz Sever, MD PhD, Irena Zupan, MD PhD, Matjaz Vrtovec, MD PhD, Ales Blinc, MD PhD

Blood (2018) 132 (Supplement 1): 2417.

https://doi.org/10.1182/blood-2018-99-111862

Published: 2018

Journal Articles

Elevation of Cardio-Ankle Vascular Index in Patients with Malignant Lymphoma Treated with R-CHOP Regimen

Naomi Shimizu, MD PhD, Yasuhiro Watanabe, MD, Shouko Nakamura, MD, Sho Tanaka, MD, Rena Oka, MD, Yuta Sato, MD PhD, Haruki Imamura, MD PhD, Takashi Yamaguchi, MD PhD, Chiaki Nakaseko, MDPhD, Emiko Sakaida, MD PhD, Hideaki Bujo, MD PhD, Kohji Shirai, MD PhD, Ichiro Tatsuno, MD PhD

Blood (2017) 130 (Supplement 1): 5151.

https://doi.org/10.1182/blood.V130.Suppl_1.5151.5151

Published: 2017

Journal Articles

High Prevalence of Peripheral Artery Occlusive Disease (PAOD) Among Patients with Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitors (TKIs): A Cross-Sectional Study

Thanawat Rattanathammethee, MD, Adisak Tantiworawit, MD, Ekarat Rattarittamrong, MD, Chatree Chai-Adisaksopha, MD, Sasinee Hantrakool, MD, Arintaya Phrommintikul, MD, Siriluck Gunaparn, RN, Lalita Norasetthada, MD

Blood (2015) 126 (23): 5140.

https://doi.org/10.1182/blood.V126.23.5140.5140

Published: 2015

Journal Articles

Hemodynamic, Functional and Structural Markers of Vascular Involvement in Primary Systemic Light Chain (AL) Amyloidosis

Kimon Stamatelopoulos, Marita Lyka, Christos Papamichail, Maria Roussou, Maria Gavriatopoulou, Constantinos Pamboucas, Evangelos Terpos, Meletios A. Dimopoulos, Efstathios Kastritis, MD

Blood (2014) 124 (21): 2029.

https://doi.org/10.1182/blood.V124.21.2029.2029

Published: 2014

Journal Articles

Peripheral Arterial Occlusive Disease (PAOD) In Chronic Phase Chronic Myeloid Leukemia Patients Treated With Nilotinib

Young-Woo Jeon, M.D., Sung-Eun Lee, M.D., Soo-Young Choi, Soo-Hyun Kim, Jin-Eok Park, Hye-Rim Jeon, Eun-Jung Jang, Dong-Wook Kim, MD, PhD

Blood (2013) 122 (21): 4018.

https://doi.org/10.1182/blood.V122.21.4018.4018

Published: 2013

Journal Articles

Apoliprotein A-I Mimetic Peptide and Sickle Vasculopathy: Mouse Model Study of Acute Administration.

Lewis L. Hsu, MD, PhD, Valeriani Bead, MD, Lita A. Freeman, Ph.D., Gregory J. Kato, MD, James G Taylor, VI, MD, Katherine C Wood, Ph.D., Biljana Musicki, PhD, Constance Tom Noguchi, PhD, Dan Berkowitz, MD, Alan T Remaley, MD, PhD, Marcelo Amar, MD

Blood (2009) 114 (22): 1521.

https://doi.org/10.1182/blood.V114.22.1521.1521

Published: 2009

Journal Articles

Total Body Irradiation (TBI) Increases Cardio-Metabolic Risk and Induces Carotid Vascular Stiffness in Survivors After Hematopoietic Cell Transplant (HCT) for Childhood Hematologic Malignancies.

K. Scott Baker, MD, MS, Lyn Steffen, PhD, Xia Zhou, MS, Aaron Kelly, Ph.D., Jill Lee, RN, MSN, CPNP-AC, Anna Petryk, MD, Alan R. Sinaiko, MD, Donald R. Dengel, PhD, Daniel A. Mulrooney, MD, MS, Julia Steinberger, MD, MS

Blood (2009) 114 (22): 3329.

https://doi.org/10.1182/blood.V114.22.3329.3329

Published: 2009

Journal Articles

A Reliable Marker of Endothelial Cell Dysfunction and Vascular Damage: Legend or Reality?

Giorgio Corinaldesi, MD, PhD, Christian Corinaldesi

Blood (2008) 112 (11): 5473.

https://doi.org/10.1182/blood.V112.11.5473.5473

Published: 2008

Journal Articles

Endothelial Function in Patients with Essential Thrombocytosis.

Maya Koren-Michowitz, MD, Batia Avni, MD, Irma Zur, MD, Yulia Volcheck, MD, Naomi Rahimi-Levene, MD, Victor Dishy, MD, Ahuva Golik, MD, Abraham Kornberg, MD

Blood (2005) 106 (11): 3983.

https://doi.org/10.1182/blood.V106.11.3983.3983

Published: 2005

NARROW

Rituximab (R)-CHOP Therapy Has Progressed Arteriosclerosis with an Elevation of Von Willebrand Factor (vWF) in Patients with Malignant Lymphoma

Arterial Function Deterioration Is Accelerated in Patients with Essential Thrombocythemia

Elevation of Cardio-Ankle Vascular Index in Patients with Malignant Lymphoma Treated with R-CHOP Regimen

High Prevalence of Peripheral Artery Occlusive Disease (PAOD) Among Patients with Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitors (TKIs): A Cross-Sectional Study

Hemodynamic, Functional and Structural Markers of Vascular Involvement in Primary Systemic Light Chain (AL) Amyloidosis

Peripheral Arterial Occlusive Disease (PAOD) In Chronic Phase Chronic Myeloid Leukemia Patients Treated With Nilotinib

Apoliprotein A-I Mimetic Peptide and Sickle Vasculopathy: Mouse Model Study of Acute Administration.

Total Body Irradiation (TBI) Increases Cardio-Metabolic Risk and Induces Carotid Vascular Stiffness in Survivors After Hematopoietic Cell Transplant (HCT) for Childhood Hematologic Malignancies.

A Reliable Marker of Endothelial Cell Dysfunction and Vascular Damage: Legend or Reality?

Endothelial Function in Patients with Essential Thrombocytosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only